Text Size

Increased anterior chamber penetration of topical levofloxacin 0.5% after pulsed dosing in cataract patients

Sundelin K., Seal D., Gardner S., Ropo A., Geldsetzer K., Lokkila J., Stenevi U.


  • 2009
  • Acta Ophthalmologica
View publication
  • Therapeutic Area

    Other

  • Categories

    Clinical development

  • Affiliations

    Department of Ophthalmology, Sahlgrenska University Hospital/Mölndal, SE-431 80 Mölndal, Sweden; Department of Ophthalmology, Sahlgrenska University Hospital, Mölndal, Sweden; Applied Vision Research Centre, City University, London, United Kingdom; OTM Inc., Atlanta, GA, United States; Santen Oy, Tampere, Finland; Department of Research and Development, Santen GmbH, Germering, Germany; Laboratory Center, Santen Oy, Tampere, Finland

Related Publications

Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality

Kempen J.H.; Newcomb C.W.; Washington T.L.; Foster C.S.; Sobrin L.; Thorne J.E.; Jabs D.A.; Suhler E.B.; Rosenbaum J.T.; Sen H.N.; Levy-Clarke G.A.; Nussenblatt R.B.; Bhatt N.P.; Lowder C.Y.; Goldstein D.A.; Leiderman Y.I.; Acharya N.R.; Holland G.N.; Read R.W.; Dunn J.P.; Dreger K.A.; Artornsombudh P.; Begum H.A.; Fitzgerald T.D.; Kothari S.; Payal A.R.; Daniel E.; Gangaputra S.S.; Kaçmaz R.O.; Liesegang T.L.; Pujari S.S.; Khachatryan N.; Maghsoudlou A.; Suga H.K.; Pak C.M.; Helzlsouer K.J.; Buchanich J.M.


Exploring Cell-Penetrating Peptides as Penetration Enhancers in Eye Drop Formulations Using a Reconstructed Human Corneal Epithelial Model

Morofuji R.; Enomoto H.; Honda T.; Oyama Y.; Ishida R.; Kudo K.; Okabe K.


Usability of an Eye Drop Delivery Aid for Single-Dose Instillation: Results from a Market Research Study

Lebrón Gutiérrez K.; Thomas S.; Martin J.L.; Dahlmann-Noor A.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022